188 related articles for article (PubMed ID: 2495286)
21. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
Schaefer EJ; Anderson DW; Zech LA; Lindgren FT; Bronzert TB; Rubalcaba EA; Brewer HB
J Lipid Res; 1981 Feb; 22(2):217-28. PubMed ID: 6787156
[TBL] [Abstract][Full Text] [Related]
22. Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5'-flanking region of the human ApoA-I gene.
Higuchi K; Law SW; Hoeg JM; Schumacher UK; Meglin N; Brewer HB
J Biol Chem; 1988 Dec; 263(34):18530-6. PubMed ID: 3142880
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
[TBL] [Abstract][Full Text] [Related]
24. Genetic heterogeneity of plasma lipoproteins in the mouse: control of low density lipoprotein particle sizes by genetic factors.
Jiao S; Cole TG; Kitchens RT; Pfleger B; Schonfeld G
J Lipid Res; 1990 Mar; 31(3):467-77. PubMed ID: 1971301
[TBL] [Abstract][Full Text] [Related]
25. SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice.
Cabana VG; Reardon CA; Wei B; Lukens JR; Getz GS
J Lipid Res; 1999 Jun; 40(6):1090-103. PubMed ID: 10357841
[TBL] [Abstract][Full Text] [Related]
26. Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.
Gong EL; Stoltfus LJ; Brion CM; Murugesh D; Rubin EM
J Biol Chem; 1996 Mar; 271(11):5984-7. PubMed ID: 8626380
[TBL] [Abstract][Full Text] [Related]
27. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
[TBL] [Abstract][Full Text] [Related]
28. Effect of experimental nephrosis on hepatic lipoprotein secretion and urinary lipoprotein excretion in rats expressing the human apolipoprotein A-I gene.
Marsh JB; Diffenderfer MR; Fisher EA; Sowden M; Dong M; Paterniti JR; Burkey BF
J Lipid Res; 1996 May; 37(5):1113-24. PubMed ID: 8725162
[TBL] [Abstract][Full Text] [Related]
29. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3.
Benvenga S; Cahnmann HJ; Rader D; Kindt M; Robbins J
Endocrinology; 1992 Dec; 131(6):2805-11. PubMed ID: 1446618
[TBL] [Abstract][Full Text] [Related]
30. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
Srivastava RA; Srivastava N; Averna M
Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
[TBL] [Abstract][Full Text] [Related]
31. Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet.
Recalde D; Baroukh N; Viglietta C; Prince S; Verona J; Vergnes L; Pidoux J; Nazeem Nanjee M; Brites F; Ochoa A; Castro G; Zakin MM; Miller NE; Marie Houdebine L
FEBS Lett; 2004 Aug; 572(1-3):294-8. PubMed ID: 15304365
[TBL] [Abstract][Full Text] [Related]
32. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
33. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice.
Reardon CA; Kan HY; Cabana V; Blachowicz L; Lukens JR; Wu Q; Liadaki K; Getz GS; Zannis VI
Biochemistry; 2001 Nov; 40(45):13670-80. PubMed ID: 11695916
[TBL] [Abstract][Full Text] [Related]
34. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity.
Guyard-Dangremont V; Lagrost L; Gambert P
J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854
[TBL] [Abstract][Full Text] [Related]
35. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma.
Nichols AV; Blanche PJ; Shore VG; Gong EL
Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein association of human apolipoprotein E/A-I chimeras. Expression in transfected hepatoma cells.
Thurberg BL; Reardon CA; Getz GS
J Biol Chem; 1996 Mar; 271(11):6062-70. PubMed ID: 8626391
[TBL] [Abstract][Full Text] [Related]
37. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
Groener JE; van Gent T; van Tol A
Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
[TBL] [Abstract][Full Text] [Related]
38. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.
Srivastava RA
Mol Cell Biochem; 2000 Jun; 209(1-2):125-9. PubMed ID: 10942210
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the cytolytic effects in vitro on Trypanosoma brucei brucei of plasma, high density lipoproteins, and apolipoprotein A-I from hosts both susceptible (cattle and sheep) and resistant (human and baboon) to infection.
Gillett MP; Owen JS
J Lipid Res; 1992 Apr; 33(4):513-23. PubMed ID: 1527475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
